Current Affairs Topics Quiz Archive
International Relations Economics Polity & Governance Environment & Ecology Science & Technology Internal Security Geography Social Issues Art & Culture Modern History

Dr. Bharti nominated to WHO’s oversight committee for neglected tropical diseases

April 18, 2026 3 min read Science & Technology International Relations GS Paper 2 (International Organisations Health Governance) GS Paper 3 (Science & Technology)
On This Page ▼

What Happened

  • Dr. Bharti has been nominated as an independent expert on neglected zoonotic diseases to the 18-member Global Oversight Committee (GOC) under the WHO's Neglected Tropical Diseases (NTD) programme.
  • The appointment recognises India's growing scientific expertise in zoonotic disease research and brings an Indian voice into the global governance of NTD medicine donation and supply chain management.
  • The GOC was formally established in January 2024 at a WHO workshop in Geneva, and works alongside the Supply Chain Technical Support Mechanism (SCTM), a five-year project implemented by JSI (John Snow, Inc.) focused on eight priority countries in Africa.
  • The nomination comes ahead of the 19th meeting of the WHO's Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD), held in April 2026 in Geneva.

Static Topic Bridges

WHO Structure and NTD Governance

The World Health Organization oversees a dedicated programme on Neglected Tropical Diseases (NTDs), currently housed within the newly merged WHO Malaria and Neglected Tropical Diseases (MNT) Department, directed by Dr. Daniel Ngamije Madandi. The principal advisory body to WHO for the control, elimination, and eradication of NTDs is the Strategic and Technical Advisory Group for Neglected Tropical Diseases (STAG-NTD), which reports directly to the WHO Director-General.

  • WHO recognises 20 NTDs in its official roadmap; six are categorised as Neglected Zoonotic Diseases (NZDs): echinococcosis, foodborne trematodiasis, human African trypanosomiasis, leishmaniasis, rabies, and taeniasis/cysticercosis.
  • Pharmaceutical partners donate over two billion doses of medicines annually to more than 70 countries; WHO handles approximately 80% of these supplies.
  • The Global Oversight Committee (GOC) was launched in 2024 specifically to address longstanding inefficiencies — stock-outs, wastage, and delays — in NTD medicine supply chains.

Connection to this news: India's nomination to the GOC places an Indian expert at the centre of global NTD supply chain governance, directly relevant to how donated medicines reach endemic countries including India itself.

Neglected Zoonotic Diseases — India's Burden

Zoonotic diseases — infections that transmit between animals and humans — disproportionately affect tropical countries. India carries one of the world's highest burdens of neglected zoonotic diseases, driven by dense human–animal interfaces, large livestock populations, and inadequate veterinary surveillance.

  • Major NZDs in India include rabies (world's highest mortality from dog-mediated rabies), brucellosis, leptospirosis, cysticercosis, echinococcosis, Japanese Encephalitis, and Kyasanur Forest Disease.
  • India ratified the Stockholm Convention on Persistent Organic Pollutants in 2006 but domestic capacity to eliminate vector-borne NTDs remains uneven across states.
  • The National Health Policy 2017 and the National Action Plan for Prevention and Control of NTDs provide the domestic policy framework.
  • AIIMS New Delhi and ICMR are among the key Indian institutions conducting NZD surveillance and research.

Connection to this news: Dr. Bharti's specialisation in neglected zoonotic diseases means India's domestic disease burden and research experience directly inform the independent expert advice she will provide to the GOC.

India's Role in International Health Governance

India increasingly participates in WHO expert panels and technical advisory groups, reflecting both its public health capacity and its status as a significant recipient and producer of essential medicines.

  • India is the world's largest producer of generic medicines, supplying over 50% of global vaccine demand and 25% of global generic drug supply by volume.
  • India holds observer or member status across multiple WHO technical advisory bodies related to polio, malaria, tuberculosis, and NTDs.
  • The WHO SEARO (South-East Asia Regional Office) covers India and actively coordinates India's NTD elimination targets under the 2030 roadmap.

Connection to this news: The GOC nomination strengthens India's institutional influence over global NTD medicine procurement and distribution policy.

Key Facts & Data

  • WHO recognises 20 Neglected Tropical Diseases affecting over 1.7 billion people globally.
  • Six are classified as Neglected Zoonotic Diseases (NZDs) — diseases at the human-animal interface.
  • The Global Oversight Committee (GOC) was established in January 2024 in Geneva.
  • Pharmaceutical companies donate over 2 billion doses/year to 70+ countries for NTD treatment.
  • India ratified the Stockholm Convention in 2006.
  • WHO's NTD and Malaria programmes were merged in 2025 into the new MNT Department.
  • India has the highest annual death toll from dog-mediated rabies globally — approximately 20,000 deaths/year.
  • The 19th STAG-NTD meeting was held on 8–9 April 2026 at WHO headquarters, Geneva.